247 related articles for article (PubMed ID: 25374152)
21. Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility.
Ferro M; Macher HC; Fornés G; Martín-Sánchez J; Jimenez-Arriscado P; Molinero P; Pérez-Simón JA; Guerrero JM; Rubio A
Transfusion; 2018 Oct; 58(10):2272-2279. PubMed ID: 30222855
[TBL] [Abstract][Full Text] [Related]
22. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
Wienzek-Lischka S; Sawazki A; Ehrhardt H; Sachs UJ; Axt-Fliedner R; Bein G
Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019
[TBL] [Abstract][Full Text] [Related]
23. Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia.
Bertrand G; Drame M; Martageix C; Kaplan C
Blood; 2011 Mar; 117(11):3209-13. PubMed ID: 21239703
[TBL] [Abstract][Full Text] [Related]
24. Successful management of neonatal alloimmune thrombocytopenia in the second pregnancy: a case report.
Conti FM; Hibner S; Costa TH; Dezan MR; Aravechia MG; Pereira RA; Kondo AT; D'Amico ÉA; Mota M; Kutner JM
Einstein (Sao Paulo); 2014; 12(1):96-9. PubMed ID: 24728253
[TBL] [Abstract][Full Text] [Related]
25. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review.
Kamphuis MM; Paridaans N; Porcelijn L; De Haas M; Van Der Schoot CE; Brand A; Bonsel GJ; Oepkes D
BJOG; 2010 Oct; 117(11):1335-43. PubMed ID: 20618318
[TBL] [Abstract][Full Text] [Related]
26. Hemolytic disease of the fetus and newborn in the molecular era.
Fasano RM
Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
[TBL] [Abstract][Full Text] [Related]
27. Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.
Brojer E; Husebekk A; Dębska M; Uhrynowska M; Guz K; Orzińska A; Dębski R; Maślanka K
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):279-90. PubMed ID: 26564154
[TBL] [Abstract][Full Text] [Related]
28. Neonatal Alloimmune Thrombocytopenia: A Concise Review.
Norton T; Newberry D; Jnah A
Adv Neonatal Care; 2021 Apr; 21(2):115-121. PubMed ID: 32657948
[TBL] [Abstract][Full Text] [Related]
29. Prediction of fetal blood group antigens from maternal plasma using Ion AmpliSeq HD technology.
Orzińska A; Kluska A; Balabas A; Piatkowska M; Kulecka M; Ostrowski J; Mikula M; Dębska M; Uhrynowska M; Guz K
Transfusion; 2022 Feb; 62(2):458-468. PubMed ID: 34997618
[TBL] [Abstract][Full Text] [Related]
30. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
[TBL] [Abstract][Full Text] [Related]
31. Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
Loewenthal R; Rosenberg N; Kalt R; Dardik R; Landau M; Yahalom V; Avishai O; Frenkel O; Gazit E; Steinberg DM; Lipitz S; Salomon O
Transfusion; 2013 Feb; 53(2):344-52. PubMed ID: 22671039
[TBL] [Abstract][Full Text] [Related]
32. Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.
Arinsburg SA; Shaz BH; Westhoff C; Cushing MM
Am J Hematol; 2012 May; 87(5):525-8. PubMed ID: 22345051
[TBL] [Abstract][Full Text] [Related]
33. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.
Bussel JB; Primiani A
Blood Rev; 2008 Jan; 22(1):33-52. PubMed ID: 17981381
[TBL] [Abstract][Full Text] [Related]
34. A man-made disease: Fetal neonatal alloimmune thrombocytopenia due to incompatibility between oocyte donor and gestational mother.
Barg AA; Ifrah AD; Strauss T; Simchen MJ; Orvieto R; Rosenberg N; Kenet G
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097780
[TBL] [Abstract][Full Text] [Related]
35. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
[TBL] [Abstract][Full Text] [Related]
36. [Detection, diagnosis and analysis of the first case of neonatal alloimmune thrombocytopenia purpura associated with anti-HPA-5b in China].
Zhou Y; Zhong ZL; Li LL; Shen WD; Wu GG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):399-402. PubMed ID: 24763012
[TBL] [Abstract][Full Text] [Related]
37. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
Bonstein L; Haddad N
Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
[TBL] [Abstract][Full Text] [Related]
38. [Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation].
Petermann R
Transfus Clin Biol; 2017 Sep; 24(3):166-171. PubMed ID: 28673503
[TBL] [Abstract][Full Text] [Related]
39. Fetal and neonatal alloimmune thrombocytopenia - The Norwegian management model.
Tiller H; Ahlen MT; Akkök ÇA; Husebekk A
Transfus Apher Sci; 2020 Feb; 59(1):102711. PubMed ID: 31911047
[TBL] [Abstract][Full Text] [Related]
40. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.
Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA
Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
